March 27, 2025 C-Path’s Predictive Safety Testing Consortium Advances a Transformative Test to Detect Drug Induced Liver Injury TUCSON, Ariz., March 27, 2025 – Researchers from Critical Path Institute’s® (C-Path) Predictive Safety Testing Consortium...
March 27, 2025 C-Path Announces Paul E. Edmeier as New Chief Financial Officer TUCSON, Ariz., March 27, 2025 — Critical Path Institute® (C-Path) today announced the appointment of Paul E. Edmeier as...
March 26, 2025 C-Path Announces Successful Conclusion of the eCOA: Getting Better Together Initiative Collaboration has culminated in meaningful, lasting changes for the benefit of stakeholders...
March 6, 2025 New Biomarkers Could Improve Early Detection, Monitoring of Kidney Injury C-Path and Boston Medical Center published results for six biomarkers that could improve the early and accurate detection...
March 6, 2025 C-Path Announces Steven W. Spector and James A. King as New Board Members C-Path announced the appointments of Steven W. Spector and James A. King to its Board of Directors...
February 18, 2025 C-Path’s CPA-1 Consortium Welcomes Newest Members Kamada, Sanofi Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada...
January 23, 2025 C-Path Announces Jennifer Kendra as New Vice President of Strategic Partnerships TUCSON, Ariz., January 23, 2025 — Critical Path Institute® (C-Path) today announced the appointment of Jennifer Kendra as...
January 14, 2025 C-Path’s TRxA Announces 2025 Request for Proposals from Academic Investigators C-Path and TRxA today officially launched its 2025 global Request for Proposals for Bridging Research...
November 19, 2024 C-Path’s TRxA Announces $1 Million Award for Drug Development Project in Type 1 Diabetes C-Path today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership...
November 13, 2024 C-Path Announces Global Evidence in Medicine for Parkinson’s Disease (GEM‑PD) Initiative C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden..